| | COVID-19 clinical operations
ICON has adopted numerous measures to protect the welfare of patients, to protect the safety of our employees and to ensure the continuity of your research programmes during COVID-19. Learn more about how to keep your trial on track in this evolving environment.
|
Today's Rundown Gilead inks deals with generics makers to supply COVID-19 therapy remdesivir for 127 countries With 'multiple shots on goal,' NIAID director Anthony Fauci is ‘cautiously optimistic’ about COVID-19 vaccine success Primary care doctors fear delayed care will lead to serious illnesses, death UnitedHealth Group has paid out $23.8M in emergency child care benefits due to COVID-19. Here's why Moderna nabs FDA fast-track tag for its COVID-19 vax Portraits in Healthcare: 'The family was asking us to … hold her hand so their mother wouldn't be alone as she passed' Healthcare roundup: Dems want to give providers $100B; BCBSA finds millennials, Gen Zers taking to telehealth Regeneron CEO: Manufacturing not up to snuff for COVID-19 vaccines, therapies LabCorp, Quest broaden availability of COVID-19 tests nationwide Here's a look at salaries of U.S. front-line workers in COVID-19 fight compared to the rest of the world Featured Story | | | Tuesday, May 12, 2020 After scoring an early authorization for its COVID-19 therapy remdesivir, Gilead Sciences has been on the hunt for manufacturing partners to help boost production for the in-demand drug. Through a series of licensing agreements, Gilead has taken the first steps to build that network. |
|
|---|
|
Top Stories Tuesday, May 12, 2020 With eight COVID-19 vaccines in human testing and headlines touting their progress each day, a leading U.S. health official voiced some optimism about one or more of them working. Tuesday, May 12, 2020 More than a third of primary care clinicians fear their patients will die because of delayed care during the COVID-19 pandemic. Clinicians predict primary care will be overwhelmed with pent-up demand, and the majority believe that some of their patients will experience avoidable illnesses, both due to diverted or avoided care, according to a new survey. Tuesday, May 12, 2020 UnitedHealth Group has launched a new program for its employees that will reimburse them for emergency child care to the tune of $100 per day. Tuesday, May 12, 2020 In what will be of little surprise to anyone, the FDA has hitched its fast-track tag to Moderna’s speedy attempt at an mRNA COVID-19 vaccine. Tuesday, May 12, 2020 At UPMC Presbyterian, Mary McFarland, R.N., was part of a team that worked to convert an ICU unit into the hospital’s first dedicated COVID-19 unit. She shares the moments that have stayed with her during the past two months of treating COVID-19 patients. Tuesday, May 12, 2020 FierceHealthcare's ongoing coverage of how the coronavirus is impacting the healthcare industry. Tuesday, May 12, 2020 Regeneron has been at the forefront of the COVID-19 fight for months with partnered med Kevzara in clinical trials and an antibody cocktail in development. But success in the clinic means nothing if drugmakers can't produce a therapy or vaccine fast enough—and Regeneron's helmsman is sounding the alarm. Tuesday, May 12, 2020 The U.S. clinical testing giants Quest Diagnostics and LabCorp are broadening the availability of their COVID-19 diagnostic tests, opening up their use nationwide. Tuesday, May 12, 2020 U.S. healthcare workers on the front lines of fighting COVID-19 are among the top paid in the world compared to other major developed nations, according to a new study released this week. |
